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1. Introduction
Members of the genus Vesivirus in the family Calicivir-
idae infect both marine and terrestrial organisms (Smith
and Boyt, 1990). Among vesiviruses known collectively as
the ‘‘marine vesiviruses’’ are 13 serotypes isolated from
swine between 1932 and 1956 called vesicular exanthema
of swine viruses (VESVs), which are considered foreign
animal disease (FAD) agents in the USA because they
sometimes cause a vesicular disease in swine clinically
indistinguishable from foot-and-mouth disease. It has
been proposed that the VESV strains were accidentally
introduced into pig herds through the ingestion of feed
contaminated with marine mammal and fish products
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A B S T R A C T
Sequences encoding the major and minor capsid proteins (VP1 and VP2) from two marine
vesivirus isolates (Steller sea lion viruses V810 and V1415)were engineered for expression
of virus-like particles (VLPs) in the baculovirus system. The resulting VLPs were
morphologically similar to native vesivirus virions. Purified VLPs were probed in
immunoblotswith pooled antisera specific for nine SanMiguel sea lion virus (SMSV) types,
and a predominant protein of approximately 60 kDa was detected. An enzyme linked
immunosorbent assay (ELISA) for the detection of antibodies was developed in which the
VLPs served as antigen. The VLPs were adsorbed to the wells of a microplate, and the
specificity of the ELISA was established with hyperimmune sera raised against 24
serotypes of the genus Vesivirus. The ELISA was used to screen for the presence of vesivirus
specific antibodies in the sera of free-ranging Steller sea lions. The ELISA results
demonstrated that Steller sea lions that inhabit the Pacific Ocean waters of southeast
Alaska are widely exposed to antigenically related marine vesiviruses, while no previous
exposure could be demonstrated using VLP antigens in 17 Steller sea lions from the
Aleutian Islands. The broad reactivity of these VLPs and their non-infectious nature will
facilitate global sero-epidemiological studies aimed at determining the incidence and
prevalence of marine vesiviruses in mammals that inhabit the Pacific and Atlantic oceans
as well as susceptible terrestrial animals.
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harboring serologically related vesiviruses (Smith et al.,
1973). Working with these viruses requires their handling
in at least a BSL-2 plus or enhanced biosafety laboratory
and special USDA-APHIS permits. Due to these restrictions,
research on marine vesiviruses has been hampered and
diagnostic reagents are not readily available to study the
distribution and impact of marine vesiviruses in marine or
terrestrial animals. The identification ofmarine vesiviruses
initially relied on virus isolation in cell culture and virus
neutralization (VN) using panels of specific antisera raised
against different isolates (Smith and Akers, 1976; Smith
and Boyt, 1990). Although more than 45 serotypes have
been established with this approach, the extent of
serotypic diversity among these viruses in not known. In
recent years, molecular approaches have been developed
to detect and genotype new isolates (McClenahan et al.,
2008; Reid et al., 1999, 2007).
Although the genotype of new isolates can be deter-
mined by nucleotide sequencing and phylogenetic ana-
lyses (Berke et al., 1997; Ganova-Raeva et al., 2004;
McClenahan et al., 2008; Neill, 1992), additional studies
are needed to understand the relationship between
genotype and serotype. Moreover, the availability of
non-restricted (non-infectious) vesivirus serologic assays
would facilitate studies of the natural history of marine
vesiviruses in their vast ecosystem. In this context, virus-
like particles (VLPs) are empty viral capsids that resemble
the capsid of the native virus, but that do not contain the
infectious viral RNA that characterizes all members of the
family Caliciviridae (Ball et al., 1996; Bertolotti-Ciarlet
et al., 2003; Di Martino et al., 2007; Jiang et al., 1992;
Laurent et al., 1994; Noad and Roy, 2003). The generation
of the first calicivirus VLPs was reported for the Norwalk
virus, a member of the genus Norovirus, following co-
expression of ORF2 and ORF3 in a single baculovirus (Jiang
et al., 1992). In members of the genus Vesivirus, the
complete capsid gene (ORF2) is translated as a precursor
protein approximately 73 kDa that is cleaved by the viral
protease encoded in ORF1 to generate a mature capsid
protein (VP1) of approximately 60 kDa (Carter et al., 1992;
Neill et al., 1991). Virus-like particles have also been
produced from the vesivirus feline calicivirus (FCV) by
expressing either the capsid precursor or mature capsid
protein in a baculovirus expression system (DeSilver et al.,
1997; Di Martino et al., 2007). However, although the
development of marine vesivirus VLPs has not been
reported, recombinant antigens of broader reactivity to
detect marine vesivirus antibodies have been recently
described; i.e., a recombinant antigen (D3A) of 293 amino
acids corresponding to a capsid fragment of SanMiguel sea
lion virus 5 (SMSV-5) expressed in a bacterial system was
reactive with antisera to more than 30 different serotypes
of marine vesiviruses (Kurth et al., 2006a). The antigenwas
also used to detect vesivirus antibodies in 15% (n = 693) of
serum samples from sick and healthy cattle (Kurth et al.,
2006a), and in the serum of mares that had aborted; in
which an increase in the frequency of antibodies from 47.1
to 88.2% was demonstrated (Kurth et al., 2006b).
We recently reported the isolation and characterization
of two unique marine vesivirus genotypes from Steller sea
lions (SSL-Eumetopias jubatus), SSL V810 and SSL V1415
(McClenahan et al., 2008). We report here the production
of VLPs from these two genotypes by expression of their
mature VP1 or VP1 and VP2 capsid proteins in a
baculovirus system. The VLPs were utilized as antigens
to develop an enzyme linked immunosorbent assay (ELISA)
for the detection of serum antibodies tomarine vesiviruses
in animals from two free-ranging populations of SSL in
Alaska.
2. Materials and methods
2.1. Viral RNA
Marine vesiviruses SSL V810 and SSL V1415 were
isolated from Alaskan Steller sea lions in Vero and Madin
Darby canine kidney (MDCK) cell cultures, respectively
(McClenahan et al., 2008). After the fourth passage in Vero
cell cultures, total RNA was extracted from the cell
monolayers at the height of cytopathogenic activity using
TRIzol-LS (Invitrogen, Carlsbad, CA) following the manu-
facturer’s protocol.
2.2. Construction of recombinant baculoviruses
Oligonucleotide primers were designed to amplify the
mature capsid gene (VP1) from the SSL vesiviruses V810
and V1415. Primers BacVFW-ORF2 (CACCATGTCG-
GATGGTCCAG) and BacVRV-ORF2 (TCCAAAATTTGCA-
TAATTCAT) were used to amplify a fragment of
approximately 1680 nucleotides (nt). During natural
vesivirus infection, the mature capsid protein is produced
post-translationally after cleavage of the full-length
precursor of the capsid protein by the virus-encoded
proteinase, so an ATG sequence was engineered into the
forward primer. Separate baculovirus constructs were also
created to express the VP1 and the protein product of ORF 3
(VP2) from a single template. BacVFW-ORF2 was used as
the forward primer and BacVRV-ORF3 (GCAACCTACCAAT-
TAACTAATTC) as the reverse primer to generate a PCR
fragment of approximately 2170 nt.
All amplified PCR products were cloned into the
Gateway vector, pENTR (Invitrogen) by Topo cloning and
plasmids containing the desired inserts were verified by
sequence analysis. Plasmid DNA was then added to a
reactionmix containing baculovirus DNA (Baculodirect kit,
Invitrogen), and the recombination reaction was per-
formed according to the manufacturer’s instructions. A
transfection mixture was prepared that contained 250 ng
recombinant baculovirus DNA, 6ml of Cellfectin (Invitro-
gen), and 2ml unsupplemented Grace’s Medium (Invitro-
gen). Following incubation at room temperature for
45min, the mixture was added to Sf-9 cells seeded at
8 105 cells per well in a 6-well plate. The transfection
mixture and cells were incubated for 5 h at 28 8C, after
which the transfection mixture was removed and replaced
with 2ml serum-free HyQ Medium (HyClone, Logan, UT)
containing 100mg/ml ganciclovir, as a negative selection
agent, and supplemented with penicillin, streptomycin
and Amphotericin B. The cultures were incubated at 28 8C
for 5 days and the cells and supernatantswere harvested as
the first passage (P1) viral stock. The P1 viral stock (5ml)
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was added to a fresh Sf-9 monolayer in the well of a 6-well
plate and maintained in the presence of 100mg/ml
ganciclovir for 120 h. The resulting P2 viral stock was
verified as free of wild-type baculovirus with a b-gal kit
(Invitrogen), and then used to infect a 100ml suspension
culture of Sf-9 cells at a multiplicity of infection (MOI) of
0.5 in the absence of ganciclovir. The resulting P3 viral
stock was titrated by plaque assay on Sf-9 cell cultures in
6-well plates, and used to infect Sf-9 suspension cultures at
a MOI of 3 for protein expression and purification.
2.3. Protein purification
Recombinant viruses were propagated in suspension
cultures of Sf-9 cells grown in 150-ml of HyQmedium. Five
days post-infection the cultures were harvested, frozen
and thawed twice, and clarified by low-speed centrifuga-
tion. The supernatants were layered onto a 25% sucrose
cushion and subjected to centrifugation in a SW28 rotor at
24,000 rpm for 4 h at 4 8C. The resulting pellets were
dissolved in phosphate buffered saline (PBS) pH 7.5 and
further purified through a cesium chloride (CsCl) gradient.
The samples were mixed with 1.6 g/cm3 of CsCl to produce
a final density of 1.38 g/cm3 as verified by refractometry.
The samples were centrifuged in a SW55Ti rotor at
48,000 rpm for 18 h at 15 8C and visible bands were
collectedwith a needle and syringe. The collected fractions
were dialyzed against PBS to remove the CsCl using a Slide-
A-Lyzer cassette (Pierce, Rockford, IL), and the protein
concentration was determined with a commercial Brad-
ford assay kit (Pierce).
2.4. SDS-PAGE and immunoblotting
The protein samples were mixed with sample loading
buffer containing 2% sodium-dodecyl sulfate (SDS), 0.5M
Tris–HCl, pH 6.8, 25% glycerol, 0.5% bromophenol blue, and
2% beta-mercaptoethanol and heated at 95 8C for 5min.
The denatured proteins were resolved by SDS polyacry-
lamide gel electrophoresis (SDS-PAGE) in 4–20% gradient
gels (Lonza, Basel, Switzerland) run at 125 V for 1.5 h with
a protein standard (Invitrogen). Proteins were transferred
onto a polyvinylidene difluoride (PVDF) membrane (Invi-
trogen) for 7min using the iBlot Gel Transfer Device
(Invitrogen). In the immunoblot analysis, the PVDF
membrane was blocked for 1 h at room temperature in
Blotto buffer (5% dried non-fatmilk in PBS). Themembrane
was then incubated with a mixture of polyclonal antisera
specific for SMSV serotypes; 1, 2, 4, 5, 6, 9, 10, 11, and 13,
diluted to 1:2000 in Blotto, incubated for 1 h with shaking
and then overnight at 4 8C. The membrane was washed
four times, 5min each time, with Western Breeze wash
buffer (Invitrogen) and incubated at room temperature for
1 h with goat anti-rabbit IgG-alkaline phosphatase con-
jugate (Pierce) (diluted 1:1000 in blocking buffer) in order
to detect binding of the primary antibodies. Themembrane
was washed four times for 10min before incubation with
the substrate BCIP/NBT (Zymed lab, South San Francisco,
CA) for 5min at room temperature. The reaction was
stopped with water and the membranes were dried prior
to photography.
2.5. Electron microscopy
Electron microscopy was used to visualize the VLPs
expressed from the recombinant baculoviruses. The
purified VLPs were adsorbed onto Formvar-coated grids,
stained with phosphotungstic acid (PTA), blotted dry, and
examined with a FEI Tecnai 12 electron microscope.
2.6. Enzyme linked immunosorbent assay
The VLPs produced from recombinant baculoviruses
expressing the mature capsid protein VP1 of vesivirus
isolates SSL V810 and SSL V1415 were each employed as an
antigen in the development of an ELISA modeled on
previously described assays (Barajas-Rojas et al., 1993;
Crowther, 2001; Ferris and Oxtoby, 1994; Kurth et al.,
2006a,b). The VLPs were diluted in carbonate–bicarbonate
buffer pH9.5 (Sigma) to a final concentration of 1mg/ml and
100ml of the dilution was added per well of a 96-well
MaxiSorp polystyrene plate (Nunc, Roskilde, Denmark).
Following adsorption of the antigen at 4 8C overnight, the
wells were washed once with 200ml wash buffer (Tris-
buffered salinewith0.1%Tween20 [TBST]) andblockedwith
200ml of blocking buffer (5% non-fat dried milk in TBST) for
1 h at 37 8C. Rabbit polyclonal antisera against various SMSV
and VESV serotypes and serum or plasma collected from
free-ranging marine mammals (primary reagents) were
titrated by performing serial two-fold dilutions in the plate
beginning at a 1:50 dilution in TBST containing 1% non-fat
driedmilk (TBST-blotto). Each serumsamplewas also tested
inat least threewellsnot coatedwithVLPs (noantigenwells)
to determine its non-specific absorbance background. The
plates were incubated for 1 h at 37 8C and subsequently
washed six times with TBST buffer. The optimal dilution
(1:3000) of the secondary reagent, protein A-peroxidase
conjugate, was determined by checkerboard titration of a
0.5mg/ml stock (Pierce) diluted inTBST-blotto, and100ml of
the optimal dilution was added to each well. The plate was
incubated at 37 8C for 1 h, followed by four washes with
200ml of TBST per well. The ABTS (2,20-azino-bis 3-
ethylbenzthiazoline-6-sulfonic acid; Kirkegaard & Perry
Laboratories, Gaithersburg, MD) substrate (100ml) was
added to eachwell and the plateswere incubated for 30min
at room temperature. The absorbance of each reaction was
readat405 nmonaSynergyplate reader (Bio-Tek,Winooski,
VT). A serumsamplewas considered to containantibodies to
marine vesiviruses if two criteria were met simultaneously.
First, the corrected absorbance value (VLP antigen absor-
bance minus no antigen absorbance) was 0.200 or greater,
and second, if the index was equal or greater than 2.0 (VLP
antigen absorbance divided byno antigen absorbance). Each
serum samplewas tested in triplicate in the blankwells. The
titer for each serum sample was expressed as the reciprocal
of the highest dilution that was positive by the two criteria
above.
2.7. Serum and plasma samples assayed in the ELISA and
virus neutralization test
Hyperimmune reference sera prepared in rabbits
specific for the various SMSV and VESV strains (Seal
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etal., 1995)wereobtained fromtheNationalAnimalDisease
Center, USDA, Ames, Iowa, and were assayed for their
reactivity in the ELISA. These included sera specific for SMSV
1,2,4, 5,6, 7, 9,10, 11,13,VESV-A48,B51,C52,D53,E54, F55,
G55, H54, I55, J56, K54, and 1934B. Hyperimmune sera
raised against FCV and mink calicivirus (MCV), both
members of the genus Vesiviruswere also examined. Serum
samples were obtained from free-ranging SSL, including 41
samples from Southeastern Alaska collected in 2004 and 17
SSL samples from the Aleutian Islands, Alaska, collected in
2005. Some sera were stored at 4 8C for several days before
long-term storage at20 8C or70 8C. The virus neutraliza-
tion (VN) test was performed as previously described
(McClenahan et al., 2008).
3. Results
3.1. Baculovirus expression of vesivirus capsid proteins
Recombinant baculoviruses expressing the VP1 protein
from SSL vesiviruses V810 and V1415 were constructed by
inserting an 1680-bp fragment of the vesiviruses VP1
gene into the baculovirus genome. A third recombinant
baculovirus was constructed by insertion of an 2170-bp
fragment corresponding to the V810 VP1 + VP2 genes into
the baculovirus genome. These recombinant viruses were
propagated twice in Sf-9 cell cultures, in the presence of
ganciclovir to screen out non-recombinant wild-type
baculovirus. Recombinant baculoviruses expressing V810
VP1, V1415 VP1, or V810 VP1 + VP2 were titrated in a
plaque-forming assay and exhibited titers of 2.3 107,
2.5 107, and 3.0 107 PFU/ml, respectively. Each of the
three recombinant baculoviruses was used to infect 150-
ml suspensions of Sf-9 cell cultures at a MOI of 3. A 500ml
sample was collected daily and the cell viability was
determined. Cell viability was over 95% prior to infection
and decreased over time, reaching 30% viability at day 5 in
all three infected cell cultures. Daily samples collected on
days 1 through 5 were analyzed by SDS-PAGE for protein
expression. The presence of an approximately 60 kDa
protein was apparent in extracts from the infected cell
pellets and in supernatants harvested from all three
recombinant baculoviruses, but not in the mock infected
cell controls (Fig. 1A–C). The baculovirus-infected material
was then subjected to isopycnic centrifugation as
described in Section 2. A visible band corresponding to a
density of 1.29 g/cm3 was evident in the upper half of the
CsCl gradient, consistent with the isolation of recombinant
VLPs. The analysis of thematerial in this band by SDS-PAGE
showed the presence of an expected 60 kDa protein
Fig. 1. SDS-PAGE analysis of SSL vesivirus proteins produced in the baculovirus expression system. Proteins were separated by SDS-PAGE and stained with
Gel Code Blue (Invitrogen). (Panels A–C) Samples were harvested daily for 5 days from recombinant baculovirus-infected Sf-9 cell cultures. Lane 1:
molecular weight marker, lanes 2 through 6: daily collections from cell pellets, lanes 7 through 11: daily collections from cell culture supernatant, lane 12:
uninfected Sf-9 cell control. (Panel A) V810 VP1, (panel B) V1415 VP1, (panel C) V810 VP1 + VP2, (panel D) proteins purified from cesium chloride gradients
of the supernatant from day 5 from the 3 recombinant viruses. Lane 1: molecular weight marker, lane 2: V810 VP1, lane 3: V1415 VP1, lane 4: V810
VP1 + VP2.
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(Fig. 1D). A protein of approximately 58 kDa co-purified
with the capsid protein in the CsCl gradient, but its identity
was not determined (Fig. 1D), consistent with the
appearance of ‘‘doublet’’ bands observed sometimes in
capsid expression studies of the caliciviruses (Belliot et al.,
2001; Kitamoto et al., 2002; Taube et al., 2005). Additional
studies will be needed to determine whether the smaller
58 kDa vesivirus protein was generated by mechanisms
such as proteolytic cleavage (degradation), alternative
processing in the baculovirus system, or initiation from an
internal methionine on the messenger RNA.
A time course analysis of VP1 expression in insect cells
was examined by immunoblotting. Baculovirus-infected
Sf-9 cell lysates in the blot were probed with a mixture of
hyperimmune sera raised against SMSV strains as
described in Section 2.4. A protein of approximately
60 kDa was detected that increased in intensity over time
(Fig. 2A–C). This protein corresponded in size to themature
VP1 protein detected in lysates of Vero cell cultures
infected with SSL vesiviruses V810 and V1415 (Fig. 2D).
3.2. Electron microscopy
Negative staining and electron microscopy of purified
protein samples from both VP1 recombinants and the
VP1 + VP2 recombinant baculoviruses revealed the pre-
sence of VLPs consistent in size (32–35 nm) and shape to
native calicivirus virions (Fig. 3).
3.3. Detection of vesivirus antibodies by ELISA
3.3.1. ELISA antibody titers of SMSV and VESV antisera
The reactivities of a panel of rabbit hyperimmune sera
directed against several SMSV and VESV strains of varying
Fig. 2. Immunoblot analysis of SSL vesivirus VP1 proteins expressed in the baculovirus expression system. The panels are the same as described above for
Fig. 1. The viral proteins were detected using a 1:2000 dilution of a mixture of type specific antibodies to San Miguel sea lion virus (SMSV) serotypes 4, 6, 9,
10, 11, and 13. A 60 kDa protein consistent with the positive control vesiviruses V810 and V1415 (panel D, lanes 5 and 6) was detected from the daily
samples and from VLPs purified in cesium chloride gradients.
Fig. 3. Electronmicrograph of virus-like particles (VLPs) expressed in the baculovirus expression system. Proteins were visualized by negative staining with
phosphotungstic acid. Shown are representative images of VLPs derived from vesivirus strain: V1415 (VP1 only—panel A), V810 (VP1 only—panel B), and
V810 (VP1 + VP2—panel C).
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serotype were examined in the ELISA using SSL vesiviruses
V810 and V1415 VLPs (Table 1). SMSV antiserum titers
ranged from 200 to 25,600, while VESV antiserum titers
ranged between 800 and 25,600 when tested against
V810 VLPs. SMSV antiserum titers ranged from 200 to
25,600 while VESV antiserum titers ranged between
1,600 and 25,600 when assayed against V1415 VLPs.
Specific antisera raised against other Vesivirus genus
members including FCV and MCV virions also reacted
with SSL vesivirus VLPs with titers as high as 25,600 for
FCV antiserum, and 800 and 1600 for MCV antiserum
(Table 1).
3.3.2. ELISA titers of marine mammal sera
A total of 58 serum samples obtained in 2004 from free-
ranging marine mammals from Southeast Alaska, and in
2005 from the Aleutian Islands, Alaska, were tested in the
V810 and V1415 ELISA for specific antibodies.When 41 sera
collected from young free-ranging SSL from Southeast
Alaska were assayed by ELISA, 36 (87.8%) were positive
for antibodies reacting with the V810 VLPs and 38 (92.7%)
were positive for the V1415 VLPs (Table 2). Antibody titers
against isolate V810 VLPs ranged from 50 to 800 with a
medianof200while titersagainst isolateV1415VLPs ranged
from 100 to 12,800with amedian of 400 (not shown). Virus
neutralizing antibody titers were demonstrated in 27
(65.9%) of 41 sera tested against isolate V810 and in 38
(92.7%) of 41 sera tested against isolate V1415 (Table 2). The
median VN antibody titer was 16 against isolate V810 and
512 against isolate V1415 (not shown). Except for four
borderline results, all 17seraobtained in2005 fromSSL from
the Aleutian Islands were negative for ELISA vesivirus
antibodies. The same 17 SSL sera were also negative for VN
antibodies against isolates V810 and V1415 (Table 2).
4. Discussion
The major capsid protein (VP1) of two recently
characterized SSL vesiviruses; V810 and V1415, was
expressed in the baculovirus system. The expressed VP1
(with or without the presence of VP2) self-assembled into
VLPs. This is an advance in the study of marine vesiviruses
because recombinant VLPs are nearly indistinguishable
from native virions, and therefore have the potential for
use as non-infectious antigens in diagnostics assays (Ball
et al., 1996). In the host, after natural infection with
caliciviruses, themost abundantly produced antibodies are
directed against the capsid protein, and a significant
proportion of these antibodies have type-specific neutra-
lizing activity (Guiver et al., 1992; Matsuura et al., 2001;
Neill et al., 1991; Tohya et al., 1991). The availability of
recombinant VLPs should also facilitate the study of
antigenic relationships among the marine vesiviruses by
providing an unlimited supply of immunogens for the
production of antisera against structural (capsid) proteins.
Such sera would enable the rapid characterization of new
vesivirus strains, and provide reference standards in the
development and validation of diagnostic assays.
Although vesiviruses encode a precursor of the capsid
protein in ORF2, we engineered the baculoviruses to
express only the predicted processed form of the VP1 by
engineering an ATG codon at the 50-end of the VP1 gene
cloned into the recombinant baculovirus. In addition, a
recombinant baculovirus also yielded VLPs when the
complete VP2 gene sequences encoded in ORF3 were
includedwith those of the VP1. Like other caliciviruses, the
VP1 gene of marine vesiviruses alone seems sufficient for
assembly of the VLPs and the co-expression of VP2 is not
necessary for capsid formation (Bertolotti-Ciarlet et al.,
Table 1
Antibody titers obtained by virus neutralization (VN) and enzyme linked immunosorbent assay (ELISA). Specific antisera to various marine vesiviruses
(SMSV) and vesicular exanthema of swine virus (VESV), as well as antisera to feline calicivirus andmink calicivirus VLPswere assayed by VNwith infectious
virus and by ELISA with VLP antigens. ND: not done.
Antiserum V810 VLP ELISA titer V810 VN titer V1415 VLP ELISA titer V1415 VN titer
SMSV-1 6,400 <4 3,200 <4
SMSV-2 12,800 <4 6,400 <4
SMSV-4 3,200 <4 3,200 <4
SMSV-5 25,600 <4 25,600 <4
SMSV-6 200 <4 200 <4
SMSV-7 25,600 <4 25,600 <4
SMSV-9 6,400 <4 6,400 <4
SMSV-10 12,800 <4 6,400 <4
SMSV-11 6,400 <4 6,400 <4
SMSV-13 25,600 <4 25,600 <4
VESV-A48 800 <4 1,600 <4
VESV-B51 3,200 <4 3,200 <4
VESV-C52 6,400 <4 25,600 <4
VESV-D53 25,600 4 25,600 4
VESV-E54 6,400 <4 12,800 <4
VESV-F55 1,600 <4 3,200 <4
VESV-G55 12,800 <4 12,800 <4
VESV-H54 12,800 <4 12,800 <4
VESV-I55 12,800 <4 12,800 <4
VESV-J56 3,200 <4 3,200 <4
VESV-K54 3,200 <4 3,200 <4
VESV-1934B 25,600 <4 25,600 <4
Feline calicivirus 25,600 ND 25,600 ND
Mink calicivirus 800 ND 1,600 ND
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2003; Di Martino et al., 2007). The ORF3 protein product
has an unknown function, but due to the basic character-
istic of the VP2 protein, it has been proposed to interact
with the viral RNA and possibly, to encapsidate the RNA of
progeny viruses (Neill et al., 1991; Prasad et al., 1999). The
VP2 protein has been shown to be a structural protein
(Glass et al., 2000; Sosnovtsev and Green, 2000), and is
necessary for infection of FCV (Sosnovtsev et al., 2005).
Previous experimentswith noroviruses indicated that VLPs
expressed from ORF2 and ORF3 sequences had higher
yields thanwhen expressed fromORF2 alone, and the VLPs
showed increased stability (Bertolotti-Ciarlet et al., 2003).
In the present study, it appeared that the V810 vesivirus
VLPs produced with both VP1 + VP2 genes exemplified the
Table 2
Antibody titers in the serum of Steller sea lions against marine vesiviruses as determined by virus neutralization (VN) using isolates V810 and V1415 and
ELISA using VLPs from the same isolates as antigen. SSL: Steller sea lion; SE: Southeast Alaska; AL: Aleutian Islands, Alaska.
Serum sample V810 VLP ELISA titer V810 VN titer V1415 VLP ELISA titer V1415 VN titer
SSL2004-499SE 200 <4 800 128
SSL2004-500SE 100 <4 800 8192
SSL2004-501SE 100 4 800 512
SSL2004-502SE <50 <4 <50 16
SSL2004-503SE 200 4 800 512
SSL2004-504SE 400 <4 400 8
SSL2004-505SE 400 <4 800 64
SSL2004-506SE 200 1024 200 512
SSL2004-507SE 400 4 400 1024
SSL2004-508SE 50 32 800 512
SSL2004-509SE 800 16 200 2048
SSL2004-510SE 200 8 400 256
SSL2004-511SE 200 16 800 4096
SSL2004-512SE <50 8 200 8192
SSL2004-513SE 200 4 3,200 16
SSL2004-514SE 400 32 6,400 512
SSL2004-515SE 50 <4 400 512
SSL2004-516SE 100 <4 100 32
SSL2004-517SE 400 <4 12,800 1024
SSL2004-518SE 100 <4 800 4096
SSL2004-519SE 100 128 200 2048
SSL2004-520SE 200 64 1,600 2048
SSL2004-521SE 100 <4 100 32
SSL2004-522SE 400 16 800 8
SSL2004-523SE 200 4 200 8
SSL2004-524SE 800 64 3,200 2048
SSL2004-525SE 800 16 800 <4
SSL2004-526SE 100 32 200 8
SSL2004-527SE 800 16 400 <4
SSL2004-528SE 400 4 800 1024
SSL2004-529SE 50 4 200 <4
SSL2004-530SE 100 4 200 128
SSL2004-531SE 100 16 800 2048
SSL2004-532SE 50 64 200 64
SSL2004-533SE 200 8 3,200 8192
SSL2004-534SE 800 1024 400 8
SSL2004-535SE <50 8 <50 128
SSL2004-536SE 100 <4 400 1024
SSL2004-537SE <50 <4 200 1024
SSL2004-538SE 100 <4 200 512
SSL2004-539SE <50 <4 <50 8
SSL2005-594AL <50 <4 <50 <4
SSL2005-595AL <50 <4 <50 <4
SSL2005-596AL <50 <4 50 <4
SSL2005-597AL <50 <4 <50 <4
SSL2005-598AL <50 <4 <50 <4
SSL2005-599AL 50 <4 <50 <4
SSL2005-600AL <50 <4 <50 <4
SSL2005-601AL <50 <4 <50 <4
SSL2005-602AL 50 <4 50 <4
SSL2005-603AL <50 <4 <50 <4
SSL2005-604AL 50 <4 50 <4
SSL2005-605AL <50 <4 <50 <4
SSL2005-606AL <50 <4 <50 <4
SSL2005-607AL <50 <4 <50 <4
SSL2005-608AL <50 <4 <50 <4
SSL2005-609AL <50 <4 <50 <4
SSL2005-610AL <50 <4 <50 <4
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traditional ‘‘cup-like’’ morphology of members of the
Caliciviridae, but further experimentationwill be needed to
determine whether there are advantages to co-expressing
VP1 and VP2 of these marine vesiviruses.
A new ELISA was developed using non-infectious VLPs
expressed from recombinant baculoviruses as antigen
coated on microtiter plate wells. Rabbit origin typing sera
against 22 marine vesiviruses (10 serotypes designated
SMSVs and 12 serotypes designated VESVs) were cross-
reactive with VLPs produced from SSL vesivirus strains
V810 and V1415. However, none of these antisera
neutralized SSL isolates V810 and V1415, indicating that
these two viruses did not belong to any of the known VESV
or SMSV serotypes tested. These findings also indicated
that the V810 andV1415VLPs can serve as broadly reactive
antigens, which recognize antibodies against many known
marine vesivirus types and strains. Recently described
ELISAs for the detection of antibodies against marine
vesiviruses have in addition to the VLPs reported here,
used both a bacterially expressed peptide, D3A and pooled
whole viruses (SMSVs 5, 13, and 17) as coating antigens
(Kurth et al., 2006a,b; Smith et al., 2006). These ELISA
coating antigens were reported to be cross-reactive with
more than 14 different marine vesivirus serotypes, which
is similar to the cross-reactivity of the VLPs described here.
The VLP-based ELISA was used in a serologic survey of
Steller sea lions living near southeast Alaska in 2004 and
the Aleutian Islands in 2005. Each of the 58 SSL sera was
assayed by VN against vesiviruses V810 and V1415, and by
ELISA against VLPs produced by recombinant baculo-
viruses expressing VP1 from isolates V810 and V1415.
Over 90% of the tested animals in Southeast Alaska were
positive for one or both vesiviruses in the ELISA. In
addition, ELISA and VN antibodies against V1415 VLPs and
the 2005 viral isolate V1415, respectively, were present in
higher titer and frequency than similar antibodies against
the V810 VLPs and the 2002 viral isolate V810. These
results may reflect a more recent exposure to vesivirus SSL
V1415-like strains circulating in 2004 versus vesivirus SSL
V810-like strains circulating in 2002 in the same popula-
tion of SSL in Southeast Alaska. An interesting finding was
the identification of 17 antibody-negative serum samples
collected in 2005 from SSL in the Aleutian Islands (Table 2).
Further screening of SSLs from this area in the near future
will be needed to determine whether animals in this
rookery have remained free of exposure to marine
vesiviruses.
In summary, we report the development, expression
and production of VLPs of marine vesiviruses from
recombinant baculoviruses, in which either the mature
capsid gene VP1 or both VP1 and VP2 sequences had been
introduced. These VLPs were consistent in appearance
with native virions both in size and structure, and the VLPs
containing VP1 were successfully used to develop an ELISA
for the detection of vesivirus antibodies. The ELISA was
shown to detect antibodies in reference hyperimmune
rabbit sera raised in the laboratory against 24 different
vesiviruses, including 12 VESV serotypes that were
isolated decades ago (1932–1956) and in the sera of
free-ranging Steller sea lions undergoing natural vesivirus
infection 4–7 years ago (2002–2005). The ELISA will make
possible for the first time, the large-scale screening of
marine mammals for infection with vesiviruses in sero-
epidemiological studies both in the North Pacific Ocean
waters, known to be a natural habitat of these viruses
(Burek et al., 2005; Skilling et al., 1987; Smith et al., 1973),
as well as in the Atlantic Ocean and Gulf of Mexico waters,
from where marine vesiviruses have not yet been isolated.
This ELISA will contribute also to the screening of
terrestrial mammals for potential exposure to pathogenic
marine vesiviruses or related vesivirus strains. Because
certain marine vesiviruses (VESVs) are restricted agents by
virtue of inducing clinical signs in swine indistinguishable
from those of foot-and-mouth disease, these safe, non-
replicating VLP antigens can now be used safely in
conventional diagnostic virology laboratories and in basic
calicivirus research.
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